Investigation of Mesoblast Limited (MESO) on Behalf of Investors, page-7

Right before the ODAC meeting, due to the FDA letter of query, SP crashed 40%. In the letter, among other things, FDA queried manufacturing consistency and lacking of trial. I thought these were valid points. These criteria apply to all drug manufacturers to maintain a high standard of medicine. Though Ryoncil has proven its worth, there's rule to follow. I decided to exit my position and watch on the sideline. On the hindsight, this was the 1st warning signal from FDA.

MSB subsequently made an announcement to calm the Market and rebut the FDAs' concern. Could this be interpreted as misleading the market?

In the ODAC meeting, the only FDA personnel voted NO. Was this not a 2nd warning signal from FDA?

MSB issued another announcement claiming overwhelming victory in the ODAC meeting. Could this be interpreted as misleading as well?

I actually bought in again after ODAC meeting, ignoring the warning signals I thought pretty ominous. I take full responsibility for my own investment decisions and bear the consequence of losing some money. But I have to say it's partly attributed to the false hope presented by company and ramping in this forum. I believe many feel the same way as me. It's just how unfortunate this became.

I wish Msb will have FDA approval sometime in the future but now I am watching on the sideline again.